25.08.2014 - Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. The...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
